VitalHub Reports Third Quarter 2025 Results

Executive Summary

• VitalHub Corp. reported Q3 2025 revenue of $32.0 M, up 94% YoY, and ARR of $93.7 M, up 75% YoY (nine‑month basis).
• Adjusted EBITDA rose 58% YoY to $7.21 M (22% of revenue), while net income before taxes fell 33% YoY to $1.59 M.
• Cash on hand increased to $123.7 M as of Sept 30, 2025, supporting ongoing integration of recent acquisitions and margin‑enhancement initiatives.

Key Details

• ARR Growth – Q3 2025 ARR = $93,693,789 (↑18% QoQ). Drivers: organic growth $1.71 M (+2%), acquisition growth $12.0 M (+15%), FX gain $0.39 M.
• Nine‑Month ARR – $93,693,789 vs. $53,452,108 a year earlier (↑75%). Drivers: organic $7.96 M (+15%), acquisitions $30.47 M (+57%), FX gain $1.81 M.
• Revenue – Q3 2025 $32,044,030 vs. $16,509,135 YoY (↑94%); nine‑month $77,576,544 vs. $48,003,531 YoY (↑62%).
• Gross Profit – 81% of revenue for both Q3 and nine‑month periods; gross profit Q3 2025 $25,881,921 (↑95% QoQ).
• EBITDA – Q3 2025 $4.78 M vs. $3.00 M YoY (↑59%); nine‑month $11.53 M vs. $8.08 M YoY (↑43%).
• Adjusted EBITDA – Q3 2025 $7.21 M (22% of revenue) vs. $4.55 M YoY (↑58%); nine‑month $19.13 M (25% of revenue) vs. $12.79 M YoY (↑49%).
• Net Income Before Taxes – Q3 2025 $1.59 M (↓33% YoY); nine‑month $5.33 M (↓7% YoY).
• Cash Position – $123,684,500 as of Sept 30, 2025 vs. $56,574,904 at Dec 31, 2024.
• Deferred Revenue – $54,851,879 vs. $35,636,002 a year earlier.
• Operating Expenses (QoQ changes):
• G&A down 82% to $6.49 M (20% of revenue).
• Sales & Marketing down 85% to $2.88 M (9% of revenue).
• R&D up 134% to $9.24 M (29% of revenue).
• Other Notable Items – Amortization of intangibles $3.32 M, business acquisition & integration costs $3.20 M, interest expense net $(0.48 M).

Notable Quotes

“In the third quarter, we achieved annual organic ARR growth of 15% and 22% adjusted EBITDA as a percent of revenue,” – Dan Matlow, CEO, VitalHub.

The release also announced a Q3 investor conference call on 2025‑11‑07 at 9:00 AM EST (registration link provided).